Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron R Hansen

Showing results (11-20 of 172) with videos related to

Pageof 18
Sort By:
European Urology Focus|June 19, 2026
Prostate Cancer Working Group 4 RecapAravind S Ravi Kumar, Aaron R Hansen
Critical Reviews in Oncology/Hematology|June 16, 2019
The microbiome and cancer for cliniciansSarah L Picardo, Bryan Coburn, Aaron R Hansen
Cancer|March 4, 2021
Health-related quality-of-life assessment of patients with solid tumors on immuno-oncology therapiesPei Jye Voon, David Cella, Aaron R Hansen
Cancers|December 28, 2019
Structure and Optimization of Checkpoint InhibitorsSarah L Picardo, Jeffrey Doi, Aaron R Hansen
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2020
Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime timeDi Maria Jiang, Robert J Hamilton, Aaron R Hansen
Annals of Translational Medicine|August 15, 2020
Biomarkers of response to immune checkpoint inhibitors for metastatic castration resistant prostate cancer: looking for the needle in the haystackHusam A Alqaisi, Esmail Al-Ezzi, Aaron R Hansen
Journal of the National Cancer Institute|December 22, 2020
Screening for Nasopharyngeal Cancer in High-Risk Populations: A Small Price to Pay for Early Disease Identification?John R de Almeida, Scott V Bratman, Aaron R Hansen
Plos One|October 23, 2019
Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscriptsMarco A J Iafolla, Sarah Picardo, Kyaw Aung, et al.
JNCI Cancer Spectrum|November 2, 2020
Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker ManuscriptsMarco A J Iafolla, Sarah Picardo, Kyaw Aung, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 24, 2014
Phase 1 trial design: is 3 + 3 the best?Aaron R Hansen, Donna M Graham, Gregory R Pond, et al.
Pageof 18

Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
European Urology Focus|June 19, 2026
Prostate Cancer Working Group 4 RecapAravind S Ravi Kumar, Aaron R Hansen
Critical Reviews in Oncology/Hematology|June 16, 2019
The microbiome and cancer for cliniciansSarah L Picardo, Bryan Coburn, Aaron R Hansen
Cancer|March 4, 2021
Health-related quality-of-life assessment of patients with solid tumors on immuno-oncology therapiesPei Jye Voon, David Cella, Aaron R Hansen
Cancers|December 28, 2019
Structure and Optimization of Checkpoint InhibitorsSarah L Picardo, Jeffrey Doi, Aaron R Hansen
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2020
Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime timeDi Maria Jiang, Robert J Hamilton, Aaron R Hansen
Annals of Translational Medicine|August 15, 2020
Biomarkers of response to immune checkpoint inhibitors for metastatic castration resistant prostate cancer: looking for the needle in the haystackHusam A Alqaisi, Esmail Al-Ezzi, Aaron R Hansen
Journal of the National Cancer Institute|December 22, 2020
Screening for Nasopharyngeal Cancer in High-Risk Populations: A Small Price to Pay for Early Disease Identification?John R de Almeida, Scott V Bratman, Aaron R Hansen
Plos One|October 23, 2019
Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscriptsMarco A J Iafolla, Sarah Picardo, Kyaw Aung, et al.
JNCI Cancer Spectrum|November 2, 2020
Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker ManuscriptsMarco A J Iafolla, Sarah Picardo, Kyaw Aung, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 24, 2014
Phase 1 trial design: is 3 + 3 the best?Aaron R Hansen, Donna M Graham, Gregory R Pond, et al.
Pageof 18